New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 31, 2014
08:41 EDTROSGRosetta Genomics announces Alzheimer's agreement with global pharma company
Rosetta Genomics announces that it has signed an agreement with a global pharmaceutical company, or GPC, in the area of Alzheimer's disease, or AD, diagnostics. Under the agreement, Rosetta will provide its microRNA profiling and other services to assist in the development of a microRNA-based diagnostic for the early detection of AD. Rosetta will leverage the GPC's expertise in AD as it is considered a pioneer in the development and commercialization of therapeutics for AD.
News For ROSG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 30, 2015
09:18 EDTROSGRosetta Genomics announces partnership with FNApath
Rosetta Genomics announces that the company has reached an agreement-in-principle with FNApath of Little Rock, Arkansas, under which Rosetta Genomics will provide endocrinologists initially testing their patients for thyroid cancer with the option of using a pathologist or laboratory of their own choosing, or FNApath, a centralized laboratory with an expertise in diagnosing thyroid cancer. In the event of an indeterminate result, the sample would then be tested with RosettaGx Thyroid Reveal, the company's thyroid neoplasia assay for the differential diagnosis of indeterminate fine needle aspirates, or FNAs.
September 22, 2015
08:58 EDTROSGRosetta Genomics receives U.S. patent for treatment of prostate cancer
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use